
    
      MBL deficient patients will be randomized in a ratio of 1:1 to receive a single dose of
      either 0.5 mg/kg or 1.0 mg/kg of intravenous rhMBL. A total of 24 patients will be treated in
      each of the rhMBL arms, (12 in the 0.5 mg/kg and 12 in the 1.0 mg/kg. All patients are to
      receive anti-infectious prophylactic supportive therapy as per institutional standards
    
  